Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva. Source:…

The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15. Source: BioSpace

Investors and analysts are wondering if the company should buy a biotech to bolster its pipeline and bottom line. Source: BioSpace

The two companies will jointly develop Imeglimin for the treatment of type 2 diabetes in Japan. Source: BioSpace

Late on Friday, Merck announced that it had pulled its application for Keytruda in combination with pemetrexed and carboplatin as a first-line treatment for metastatic nonsquamous NSCLC from the EMA.…

Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture. Source: BioSpace

As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta. Source: BioSpace

Want to work for a company having a growth spurt? Source: BioSpace

Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.…

Amazon, as most everyone knows, has its fingers in a lot of pies. Source: BioSpace